Hamburg AoRtic Valve cOhoRt

The primary aim of the study is to identify the optimal treatment modality for patients with aortic valve disease, incorporating the individual patient's risk profile and anticipated clinical outcomes. This includes the association of demographic factors, procedural data and biomarkers with clinical outcome in a prospective fashion.

NCT Number	NCT04227002
Lead Sponsor	Universitätsklinikum Hamburg-Eppendorf
Conditions	Aortic Valve Stenosis
Enrollment	15,000 participants
Start Date	2019-09-01
Primary Completion	2039-09-01 (estimated)
Study Completion	2049-09-01 (estimated)
Updated on ClinicalTrials.gov	2020-01-13